These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10372223)

  • 1. [Incidence of disposition for malignant hyperthermia in patients with neuromuscular diseases. F. Wapplet, et al., AINS 1998;33:373-80].
    Breucking E; Mortier W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):324-7. PubMed ID: 10372223
    [No Abstract]   [Full Text] [Related]  

  • 2. [Incidence of disposition for malignant hyperthermia in patients with neuromuscular diseases].
    Wappler F; Scholz J; von Richthofen V; Fiege M; Köchling A; Matschke J; Winkler G; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Jun; 33(6):373-80. PubMed ID: 9689395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant hyperthermia.
    Heiman-Patterson TD
    Semin Neurol; 1991 Sep; 11(3):220-7. PubMed ID: 1947484
    [No Abstract]   [Full Text] [Related]  

  • 4. Anesthesia in neuromuscular diseases.
    Breucking E; Mortier W
    Acta Anaesthesiol Belg; 1990; 41(2):127-32. PubMed ID: 2196754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of malignant hyperthermia susceptibility in Denmark.
    Ording H
    Dan Med Bull; 1996 Apr; 43(2):111-25. PubMed ID: 8741205
    [No Abstract]   [Full Text] [Related]  

  • 6. Halothane-caffeine contracture testing in neuromuscular diseases.
    Heiman-Patterson TD; Rosenberg H; Fletcher JE; Tahmoush AJ
    Muscle Nerve; 1988 May; 11(5):453-7. PubMed ID: 3374516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central core disease. Clinical features in 13 patients.
    Shuaib A; Paasuke RT; Brownell KW
    Medicine (Baltimore); 1987 Sep; 66(5):389-96. PubMed ID: 3626847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative management of the paediatric patient with coexisting neuromuscular disease.
    Lerman J
    Br J Anaesth; 2011 Dec; 107 Suppl 1():i79-89. PubMed ID: 22156273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular genetic tests are not yet useful for diagnosis of malignant hyperthermia].
    Ranklev-Twetman E; Isander G; Fletcher R
    Lakartidningen; 1992 May; 89(21):1869. PubMed ID: 1598048
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant hyperthermia.
    Larach MG
    Science; 1992 Jul; 257(5066):11-2. PubMed ID: 1621085
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anesthesia in neuromuscular diseases. More security in rare cases].
    Roewer N; Kranke P
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Nov; 44(11-12):746-7. PubMed ID: 19918706
    [No Abstract]   [Full Text] [Related]  

  • 12. Critical illness neuromyopathy: from risk factors to prevention.
    De Jonghe B; Finfer S
    Am J Respir Crit Care Med; 2007 Mar; 175(5):424-5. PubMed ID: 17303895
    [No Abstract]   [Full Text] [Related]  

  • 13. [Atypical malignant hyperthermia. A higher incidence than expected].
    Herrero E; Casinello F; de Stefano J; Fernández-Guisasola J; Pérez-Gallardo A
    Rev Esp Anestesiol Reanim; 1996 Jan; 43(1):42-3. PubMed ID: 8851836
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neuromuscular diseases and anesthesia].
    Blanco D; García M; Alloza P
    Neurologia; 1993 Jan; 8(1):13-27. PubMed ID: 8442989
    [No Abstract]   [Full Text] [Related]  

  • 15. Sudden infant death syndrome and malignant hyperthermia diathesis.
    Peterson DR; Davis N
    Aust Paediatr J; 1986; 22 Suppl 1():33-5. PubMed ID: 3790001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hyperthermia and related neuromuscular diseases: caffeine contracture of the skinned muscle fibers.
    Takagi A; Sunohara N; Ishihara T; Nonaka I; Sugita H
    Muscle Nerve; 1983 Sep; 6(7):510-4. PubMed ID: 6633564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant hyperthermia: screening of a family by serum-enzymes, electromyography and nerve-conduction.
    Kratholm S; Nielsen E
    Anaesth Resusc Intensive Ther; 1974; 2(4):359-63. PubMed ID: 4460754
    [No Abstract]   [Full Text] [Related]  

  • 18. Statin-induced adverse effects and malignant hyperthermia susceptibility: comment on the article by Guis et al.
    Vladutiu G
    Arthritis Rheum; 2007 Feb; 57(1):186-7; author reply 187-8. PubMed ID: 17266123
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome and malignant hyperthermia susceptibility.
    Tweed WA
    Acta Anaesthesiol Scand; 1990 Oct; 34(7):605. PubMed ID: 2244451
    [No Abstract]   [Full Text] [Related]  

  • 20. Incidence of malignant hyperthermia in Denmark.
    Ording H
    Anesth Analg; 1985 Jul; 64(7):700-4. PubMed ID: 4014731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.